The IDM has curated a go-to range of reliable information to guide and assist staff and students during this time of crisis. We are continuously updating the various COVID-19 resources listed on our webpage below.
The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.
IDM driving world class research
We conduct research at the laboratory-clinic-community interface by engaging a wide range of scientific and clinical disciplines; with 62 consortia linking us with 183 institutions in 22 African countries and 24 countries beyond.
University accredited research institute - Tackling diseases of importance in Africa - Developing people - Impacting health policy and practice
The University of Cape Town’s (UCT) Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) has awarded “pump-priming” funding for six COVID-19 research projects.
Science meets Science Culture in the Sister Institute Seminar Series which was launched, in partnership with the University of Cape Town’s Institute of Infectious Disease and Molecular Medicine (IDM), at the beginning of this month.
The University of Cape Town’s (UCT) Biopharming Research Unit (BRU), under the leadership of Professor Ed Rybicki, has received government funding to assist in the production of diagnostic reagents for COVID-19.
In a recent speech by Blade Nzimande, Minister of Higher Education, Science and Technology, announced that the Department of Science and Innovation (DSI) is increasing funding awards to South Africa's COVID-19 Testing Ability. The University of Cape Town’s Biopharming Research Unit (BRU) is one of the recipients of this funding.
